CLINICAL Correlation Between Breast Cancer And Prognostic Significance Of Ferritin, Vitamin D AND Vitamin B12
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2024/04/065047
- Lead Sponsor
- Akansha Hatewar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Newly diagnosed case of CA breast and biopsy proven.
2 Women aged above 18 years.
Exclusion Criteria
1 Malignancies other than breast carcinoma
2 Pregnancy/puerperium
3 Known c/o Tuberculosis, Chronic inflammatory diseases
4 Patients infected with hepatitis B and C virus as well as H.I.V.
5 Renal/Hepatic insufficiency
6 Metabolic bone disorders
7 No history of medications such as iron, levothyroxine and vitamin D/B12 supplements in the past three months
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 To estimate levels of serum vit D, Vit B12, and Ferritin in patients with stages of breast cancer. <br/ ><br>2 To analyse a correlation between serum vit D, Vit B12, Ferritin with Tumour grade, histopathological subtype and axillary lymph node status. <br/ ><br>3 To correlate between serum vit D, Vit B12, and Ferritin with molecular pathological parameters. <br/ ><br>Timepoint: 2 years
- Secondary Outcome Measures
Name Time Method 1. In this study we aim to conduct a comprehensive analysis by comparing serum expression levels of vitamin B12 vitamin D & ferritin among three distinct groups healthy individuals patients with benign breast conditions & those diagnosed with breast cancer. <br/ ><br>2. Our primary focus is to assess the intricate relationship between vitamin B12 vitamin D & ferritin levels & the associated risk of breast cancer. <br/ ><br>Timepoint: 2 years